A Phase II Trial Evaluating The Efficacy of Radioiodinated Tositumomab (anti-CD20) Antibody, Etoposide and Cyclophosphamide followed by Autologous Transplantation, for Relapsed or Refractory Non-Hodgkin's Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2010
At a glance
- Drugs Iodine-131 tositumomab (Primary) ; Cyclophosphamide; Etoposide
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 26 Aug 2010 New trial record